NDLI: The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009

Content Provider	Springer Nature : BioMed Central
Author	Haslam, Alyson Gill, Jennifer Crain, Tyler Herrera-Perez, Diana Chen, Emerson Y. Hilal, Talal Kim, Myung S. Prasad, Vinay
Abstract	Background Identifying ineffective practices that have been used in oncology is important in reducing wasted resources and harm. We sought to examine the prevalence of practices that are being used but have been shown in RCTs to be ineffective (medical reversals) in published oncology studies. Methods We cross-sectionally analyzed studies published in three high-impact oncology medical journals (2009–2018). We abstracted data relating to the frequency and characterization of medical reversals. Results Of the 64 oncology reversals, medications (44%) represented the most common intervention type (39% were targeted). Fourteen (22%) were funded by pharmaceutical/industry only and 56% were funded by an organization other than pharmaceutical/industry. The median number of years that the practice had been in use prior to the reversal study was 9 years (range 1–50 years). Conclusion Here we show that oncology reversals most often involve the administration of medications, have been practiced for years, and are often identified through studies funded by non-industry organizations.
Related Links	https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-021-08632-8.pdf
Ending Page	9
Page Count	9
Starting Page	1
File Format	HTM / HTML
ISSN	14712407
DOI	10.1186/s12885-021-08632-8
Journal	BMC Cancer
Issue Number	1
Volume Number	21
Language	English
Publisher	BioMed Central
Publisher Date	2021-08-03
Access Restriction	Open
Subject Keyword	Cancer Research Oncology Surgical Oncology Health Promotion and Disease Prevention Biomedicine Medicine Public Health Medical reversal Low-value care Medicine/Public Health
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology Genetics
Journal Impact Factor	3.4/2023
5-Year Journal Impact Factor	3.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Medical oncology outpatients’ preferences and experiences with advanced care planning: a cross-sectional study

The impact of medical tourism on colorectal screening among Korean Americans: A community-based cross-sectional study

Breast cancer care in northern Ethiopia – cross-sectional analysis

The supportive care needs of women experiencing gynaecological cancer: a Western Australian cross-sectional study

Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d'Ivoire in 2018: a cross-sectional study

The 2018 Nobel Prize in medicine goes to cancer immunotherapy

Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study

Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey

Plasma prolactin in patients with colorectal cancer

The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009–2018

Similar Documents

Medical oncology outpatients’ preferences and experiences with advanced care planning: a cross-sectional study

The impact of medical tourism on colorectal screening among Korean Americans: A community-based cross-sectional study

Breast cancer care in northern Ethiopia – cross-sectional analysis

The supportive care needs of women experiencing gynaecological cancer: a Western Australian cross-sectional study

Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d'Ivoire in 2018: a cross-sectional study

The 2018 Nobel Prize in medicine goes to cancer immunotherapy

Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study

Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey

Plasma prolactin in patients with colorectal cancer

The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009–2018